Literature DB >> 2330873

Morphologic findings in saphenous veins used as coronary arterial bypass conduits for longer than 1 year: necropsy analysis of 53 patients, 123 saphenous veins, and 1865 five-millimeter segments of veins.

J M Kalan1, W C Roberts.   

Abstract

Certain clinical and necropsy findings are described in 53 patients who died from 13 to 185 months (mean 58) after a single aortocoronary bypass operation. Of the 53 patients, 32 (60%) died of a cardiac cause and of their 72 saphenous vein aortocoronary conduits, 36 (49%) were narrowed at some point more than 75% in cross-sectional area by atherosclerotic plaque; the remaining 21 patients (40%) died of a noncardiac cause and of their 50 saphenous vein conduits, 10 (20%) were narrowed at some point more than 75% in cross-sectional area by plaque. Thus the noncardiac mode of death in a large percentage of the patients suggests that the bypass operation prolonged life to a degree sufficient for another condition to develop. The 123 saphenous vein conduits were divided into 5 mm segments, and a histologic section was prepared from each. Of the 1104 five-millimeter segments in the 32 patients dying as a consequence of myocardial ischemia, 291 (26%) were narrowed more than 75% in cross-sectional area by plaque; in contrast, of the 761 five-millimeter segments of veins in the 21 patients with a noncardiac mode of death, 86 (11%) were narrowed more than 75% by plaque. Of the total 1865 five-millimeter segments of vein, only 395 (21%) were narrowed 25% or less in cross-sectional area by plaque. Thus, in patients dying late after coronary bypass the atherosclerotic process continues in all segments of the saphenous veins used as aortocoronary conduits. Therapy after the operation must be directed toward prevention of progression of the atherosclerosis in the "new" coronary "arteries."

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2330873     DOI: 10.1016/s0002-8703(05)80249-2

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  14 in total

1.  Correlation of tissue drug concentrations with in vivo magnetic resonance images of polymer drug depot around arteriovenous graft.

Authors:  Shawn C Owen; Huan Li; William G Sanders; Alfred K Cheung; Christi M Terry
Journal:  J Control Release       Date:  2010-05-08       Impact factor: 9.776

2.  Real-world experience of drug-eluting stents in saphenous vein grafts compared to native coronary arteries: results from the prospective multicenter German DES.DE registry.

Authors:  Ibrahim Akin; Marcus Wiemer; Steffen Schneider; Jochen Senges; Matthias Hochadel; Gert Richardt; Mohamed Abdel-Wahab; Karl-Heinz Kuck; Christoph A Nienaber
Journal:  Clin Res Cardiol       Date:  2011-11-13       Impact factor: 5.460

3.  William Clifford Roberts, MD: an interview by W. Bruce Fye, MD.

Authors:  William C Roberts; W Bruce Fye
Journal:  Proc (Bayl Univ Med Cent)       Date:  2007-07

4.  Role of endothelial cell denudation and smooth muscle cell dedifferentiation in neointimal formation of human vein grafts after coronary artery bypass grafting: therapeutic implications.

Authors:  Y Sasaki; S Suehiro; A E Becker; H Kinoshita; M Ueda
Journal:  Heart       Date:  2000-01       Impact factor: 5.994

5.  Longer coronary anastomosis provides lower energy loss in coronary artery bypass grafting.

Authors:  Hiroyuki Tsukui; Manabu Shinke; Young Kwang Park; Kenji Yamazaki
Journal:  Heart Vessels       Date:  2016-08-02       Impact factor: 2.037

6.  Time-dependent thickening of the intima in aortocoronary saphenous vein grafts: clinicopathological analysis of 24 patients.

Authors:  T Yamada; T Itoh; S Nakano; O Tokunaga
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

7.  Saphenous vein graft near-infrared spectroscopy imaging insights from the lipid core plaque association with clinical events near-infrared spectroscopy (ORACLE-NIRS) registry.

Authors:  Barbara A Danek; Aris Karatasakis; Aya J Alame; Phuong-Khanh J Nguyen-Trong; Judit Karacsonyi; Bavana Rangan; Michele Roesle; Amy Atwell; Erica Resendes; Jose Roberto Martinez-Parachini; Rahel Iwnetu; Pratik Kalsaria; Furqan Siddiqui; James E Muller; Subhash Banerjee; Emmanouil Brilakis
Journal:  Catheter Cardiovasc Interv       Date:  2016-08-18       Impact factor: 2.692

8.  Study of gene delivery in a rabbit vein graft model. Improvement of the efficiency of gene transfer into vein grafts.

Authors:  M Chikada; M Jones
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-05

Review 9.  Role of smooth muscle cells in coronary artery bypass grafting failure.

Authors:  Kerry Wadey; Joshua Lopes; Michelle Bendeck; Sarah George
Journal:  Cardiovasc Res       Date:  2018-03-15       Impact factor: 10.787

10.  Long-term engraftment of bone marrow-derived cells in the intimal hyperplasia lesion of autologous vein grafts.

Authors:  Yanpeng Diao; Steve Guthrie; Shen-Ling Xia; Xiaosen Ouyang; Li Zhang; Jing Xue; Pui Lee; Maria Grant; Edward Scott; Mark S Segal
Journal:  Am J Pathol       Date:  2008-02-14       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.